LINCOLN PHARMACEUTICALS
Back to Cashflow Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹63 Cr | ₹39 Cr | ₹76 Cr | ₹69 Cr | ₹75 Cr |
What is the latest Cash Flow from Operating Activities ratio of LINCOLN PHARMACEUTICALS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹63 Cr |
Mar2023 | ₹39 Cr |
Mar2022 | ₹76 Cr |
Mar2021 | ₹69 Cr |
Mar2020 | ₹75 Cr |
How is Cash Flow from Operating Activities of LINCOLN PHARMACEUTICALS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹63 Cr | 61.01 | |
Mar2023 | ₹39 Cr | -48.43 | |
Mar2022 | ₹76 Cr | 9.91 | |
Mar2021 | ₹69 Cr | -8.15 | |
Mar2020 | ₹75 Cr | - |
Compare Cash Flow from Operating Activities of peers of LINCOLN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LINCOLN PHARMACEUTICALS | ₹1,043.4 Cr | -6.8% | -30.4% | -15.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LINCOLN PHARMACEUTICALS | -6.8% |
-30.4% |
-15.7% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses